Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the anti-tumor activity, safety and tolerance of toripalimab as monotherapy for
patients with small cell esophageal cancer (SCCE), and to explore the potential biomarkers
for this treatment.